Colorectal Neoplasia
11
3
3
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (11)
Trial of Underwater Versus Gas-Insufflation Colorectal Endoscopic Submucosal DisseEtion
A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy
Total Underwater Colonoscopy (TUC) for Improved Colorectal Cancer Screening: A Randomized Controlled Trial
Study on the Correlation Between Serum and Fecal Sialic Acid Levels and Tumor Characteristics as Well as Postoperative Anastomotic Leakage in Patients With Colorectal Tumors
Exploratory Clinical Study of Claudin18.2-Targeted CAR-DC and CAR-T Therapy in Advanced Colorectal Cancer
The Longterm Risk of Advanced Colorectal Neoplasia After Colonoscopy - A Population-based Cohort Study in Hong Kong
Endoscopic Characterization of Colorectal Neoplasia With the Different Published Classifications
Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection
Colorectal Cancer Screening Intervention in UWPN Clinics
Association Between Confocal Laser Endomicroscopic (CLE) Features and Colorectal Mucosal Microbiome
Non-cathartic Computed Tomographic Colonography to Screen Subjects With a Family History of Colorectal Cancer